At a glance:
News
We would like to invite you to participate in the SLAS Mentor Match program. SLAS is committed to transforming life sciences through research. We are an international professional society of academic, industry and government researchers as well as developers and providers of laboratory automation tools. The SLAS mentor program was developed to encourage experienced professionals (mentors) in our diverse community to pass on their knowledge and experience to young professionals (mentees).
The agreement will facilitate understanding of complex relationships between microbiome, food and other factors, including potential causes of health and disease
Shenzhen, China and Cambridge, UK, 11 January, 2022: NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and PhoreMost Limited (PhoreMost), the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, today announced an oncology drug discovery research collaboration.
Cambridge, UK - 12 January 2022 – Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator empowering life science researchers with high-quality biological reagents and tools critical to research, drug discovery and diagnostics, today received the Employees’ Choice Award 2022 recognizing Abcam in Glassdoor’s Best Places to Work in the UK. Abcam is the first biotech company to be ranked in the top five for two years in a row (1).
12th January 2022 (Rotterdam/Cambridge) – F.INSTITUTE, a Dutch full-service finance company for Life Sciences, Clean and Deep Tech companies, has expanded its portfolio with the launch of three new products: the Incubator, Seed and Series packages. The company has also expanded its CFO Services to include Partnering and M&A Services, and Fundraising Services. These products emphasize F.INSTITUTE’s ambition to become the European one-stop market leader for financial services for start-ups and scale-ups.
After 15 years in Biotech Tom Froggatt set up Singular Talent to help Biotech companies engage, attract and secure the talent they need and to make the hiring experience better from both sides of the table. He revealed how the values that are the bedrock of the company and .... much more:
Why I started Singular Talent
Fremont, CA, US and Cambridge, UK – 04 January 2022 – Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, today announced a strategic partnership to further understanding of the human proteome.
MAINZ, Germany and CAMBRIDGE, UK, January 10, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Crescendo Biologics Ltd (“Crescendo”), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and other diseases. The initial term of the discovery collaboration is three years.